Exhibit 107

Calculation of Filing Fee Table

Form S-1

(Form Type)

CNS Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common stock, par value $0.001 per share(2)

457(o)

–

–

$7,000,000.00

0.00015310

1,071.70

Fees to Be Paid

Equity

Pre-Funded Warrants to purchase shares of common stock(3)

457(g)

–

–

(4)

Fees to Be Paid

Equity

Common Stock underlying the Pre-Funded Warrants(2)(3)

457(o)

–

–

(3)

0.00015310

(3)

Fees to Be Paid

Equity

Series F Warrants to purchase shares of common stock

457(g)

–

–

(4)

Fees to Be Paid

Equity

Common Stock underlying the Series F Warrants to purchase Common Stock(2)

457(o)

–

–

$7,000,000.00

0.00015310

1,071.70

Fees Previously Paid

–

–

–

–

–

–

–

Carry Forward Securities

Carry Forward Securities

–

–

–

–

–

–

–

–

–

Total Offering Amounts

$14,000,000.00

2,143.40

Total Fees Previously Paid

–

Total Fee Offsets

–

Net Fee Due

2,143.40

(1)	Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(o) under the Securities Act of 1933 (the “Securities Act”).
(2)	Pursuant to Rule 416 under the Securities Act, the securities registered hereby also include an indeterminate number of additional securities as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations, or other similar transactions.
(3)	The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $7,000,000.00.
(4)	No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.